Top Cancer Currents Stories of 2023

Having trouble viewing this email? View it as a Web page.

Dear Cancer Currents subscriber, As we approach the end of another year, we find ourselves reflecting on the fact that modern-day cancer research is as diverse as it is remarkable. Researchers continue to develop innovative ways to exploit weaknesses in cancer cells; make surgery and radiation more precise and effective; understand cancer's effects on the physical, mental, and financial well-being of those with the disease and their loved ones—and much, much more. Our top stories of the year capture some of the most exciting advances and significant discoveries in cancer research and provide a peek at the potential advances on the horizon. So, if you missed them the first time around, here's your chance to catch up! Finally, as we inch closer to our 10th year of publication, the writers and editors of Cancer Currents would like to thank you for your continued support. If you find our reporting important or helpful, please share it with friends and colleagues and encourage them to subscribe. Wishing you a happy and safe 2024, The Cancer Currents editorial team Top Stories of 2023 In Mouse Study, KRAS-Targeted Drug Shows Potential against Pancreatic Cancer 01/12/2023     Immunotherapy and… Nothing Else? Studies Test Potential Paradigm Shift in Cancer Treatment 02/23/2023     Study Probes Awareness of Alcohol's Link to Cancer 01/18/2023     Study Identifies Potential Warning Signs of Colorectal Cancer in Younger Adults 06/15/2023     Lung-Sparing Surgery Is Effective for Some with Early-Stage Lung Cancer 03/09/2023     New Class of Compounds Rewires Cancer Cells to Self-Destruct 08/29/2023     Study Adds to Debate about Mammography in Older Women 09/12/2023     Help Desk for Oncologists Treating People with a Rare Leukemia Pays Big Dividends 02/02/2023     FDA Approves New Initial Treatment Option for Some Metastatic Prostate Cancers 08/04/2023     ENLACE Study Explores Colorectal Cancer in Hispanic and Latino People 10/18/2023     Trial Results Confirm Effectiveness of Atezolizumab Against a Rare Sarcoma 10/20/2023

 

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892